32
9
3
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T60922 |
RSK-IN-1
|
||
RSK-IN-1 (compound 7d) 显示出抗癌活性。RSK-IN-1 是RSK 的抑制剂,可抑制 YB-1 的磷酸化。 | |||
T14779 |
BRD7389
|
SGK; FLT; Pim; CDK; S6 Kinase; DAPK | Angiogenesis; Apoptosis; Cell Cycle/Checkpoint; Chromatin/Epigenetic; JAK/STAT signaling; MAPK; Metabolism; PI3K/Akt/mTOR signaling; Tyrosine Kinase/Adaptors |
BRD7389 是一种 RSK 家族激酶抑制剂,对 RSK1、RSK2 和 RSK3 的 IC50 分别为 1.5 μM、2.4 μM 和 1.2 μM。 | |||
T6877 |
LJH685
|
Apoptosis; S6 Kinase | Apoptosis; MAPK; PI3K/Akt/mTOR signaling |
LJH685 是一种选择性,ATP-竞争性的RSK 抑制剂, 抑制 RSK1/2/3 生物活性,IC50为 6、5、4 nM。 | |||
T22422 |
S6K-18
|
S6 Kinase | MAPK; PI3K/Akt/mTOR signaling |
S6K-18 是一种高度选择性的 S6K1 抑制剂,抑制 S6K1,IC50 为 52nM。 | |||
T5428 |
BIX 02565
|
LRRK2; S6 Kinase | Autophagy; MAPK; PI3K/Akt/mTOR signaling |
BIX 02565 是核糖体 S6 激酶 2 (RSK2) 抑制剂,IC50为 1.1 nM。 | |||
T2002 |
PF-4708671
PF4708671 |
S6 Kinase; Autophagy | Autophagy; MAPK; PI3K/Akt/mTOR signaling |
PF-4708671 是一种可渗透细胞的 p70 核糖体 S6 激酶抑制剂,对 S6K1的Ki 为 20 nM,IC50为 160 nM。 | |||
T4301 |
AD80
|
Raf; c-RET; Src; S6 Kinase | Angiogenesis; Apoptosis; MAPK; PI3K/Akt/mTOR signaling; Tyrosine Kinase/Adaptors |
AD80 是多激酶抑制剂,可抑制 RET、RAF、SRC 和 S6K,并大大降低 mTOR 活性。 | |||
T6878 |
LJI308
|
S6 Kinase | MAPK; PI3K/Akt/mTOR signaling |
LJI308 是泛RSK 抑制剂,对 RSK1、RSK2 和 RSK3 的IC50分别为 6、4 和 13 nM。它抑制辐照、EGF 处理和表达 KRAS 突变的细胞中 RSK (T359/S363) 和 YB-1 (S102) 的磷酸化。 | |||
T6171 |
BI-D1870
|
S6 Kinase; Autophagy | Autophagy; MAPK; PI3K/Akt/mTOR signaling |
BI-D1870 是一种可渗透细胞和透过血脑屏障的的 ATP 竞争性核糖体 S6 激酶抑制剂,抑制 RSK1、RSK2、RSK3和 RSK4 的 IC50值分别为 31 nM、24 nM、18 nM 和15 nM。 | |||
T6948 |
Pluripotin
SC1 |
ERK; Raf; S6 Kinase | MAPK; PI3K/Akt/mTOR signaling |
Pluripotin (SC1) 是ERK1和RasGAP 的双重抑制剂,KD 分别为 98 和 212 nM。它还抑制RSK1、RSK2、RSK3和RSK4,IC50分别为 0.5、2.5、3.3 和 10.0 μM。 | |||
T6304 |
AT7867
|
Akt; PKA; S6 Kinase | Cytoskeletal Signaling; MAPK; PI3K/Akt/mTOR signaling; Tyrosine Kinase/Adaptors |
AT7867 是 ATP 竞争性的Akt1/Akt2/Akt3和p70S6K/PKA 抑制剂,IC50分别为 32、17、47 和 85、20 nM。 | |||
T6159 |
LY-2584702 free base
|
S6 Kinase; mTOR | MAPK; PI3K/Akt/mTOR signaling |
LY-2584702 free base 是一种选择性的 ATP 竞争性 p70S6K 抑制剂,IC50为 4 nM,对S6K1的IC50为 2 nM,用于研究癌症治疗的试验。 | |||
T7790 |
Bisindolylmaleimide V
双吲哚马来酰亚胺 V,双吲哚马来酰亚胺 |
PKC; S6 Kinase | Chromatin/Epigenetic; Cytoskeletal Signaling; MAPK; PI3K/Akt/mTOR signaling |
Bisindolylmaleimide V 是一种弱蛋白激酶 C (PKC) 抑制剂( IC50 >100 µM)。 | |||
T1746 |
LY-2584702 tosylate salt
LY2584702 tosylate |
S6 Kinase | MAPK; PI3K/Akt/mTOR signaling |
LY-2584702 tosylate salt 是一种选择性的 ATP 竞争性 p70S6K 抑制剂,IC50为 4 nM,对S6K1的IC50为 2 nM,用于研究癌症治疗的试验。 | |||
T4488 |
GSK-25
GSK25 |
ROCK; S6 Kinase; mTOR | Cell Cycle/Checkpoint; Cytoskeletal Signaling; MAPK; PI3K/Akt/mTOR signaling; Stem Cells |
GSK-25 是一种选择性的,具有口服活性的 ROCK1抑制剂。它对 31 种激酶以及 RSK1 和 p70S6K 保持良好的选择性,RSK1的 IC50 为 398 nM,p70S6K 的 IC50 为 1000nM。它可抑制 P450,对 CYP2C9、CYP2D6和 CYP3A4的 IC50分别为2.5、5.2和2.5 μM。 | |||
T2482 |
AT13148
|
ROCK; SGK; Akt; PKA; S6 Kinase | Cell Cycle/Checkpoint; Cytoskeletal Signaling; MAPK; Metabolism; PI3K/Akt/mTOR signaling; Stem Cells; Tyrosine Kinase/Adaptors |
AT13148 是一种 ATP 竞争性 AGC 激酶口服抑制剂,能够抑制 Akt1/Akt2/Akt3、p70S6K、PKA 和 ROCKI/ROCKII 的活性,IC50值分别为 38/402/50、8、3 和 6 nM/4 nM。 | |||
T62718 |
RSK2-IN-3
|
||
RSK2-IN-3 (Compound 26) 是一种共价的、可逆的 RPS6KA3 (RSK2) 激酶抑制剂。 | |||
T60585 |
RSK2-IN-2
|
||
RSK2-IN-2 (Compound 25) 是 RPS6KA3 (RSK2) 激酶的可逆共价抑制剂,它也能抑制MSK1、MSK2和RSK3。 | |||
T8978 |
DD1
3,3'-Diamino-4'-methoxyflavone,HUN85111 |
Proteasome | Proteases/Proteasome; Ubiquitination |
DD1 (HUN85111) 是一种蛋白酶体抑制剂,可诱导人髓系肿瘤选择性凋亡。 | |||
T61766 |
RSK4-IN-1
|
||
RSK4-IN-1 具有有效的 RSK4抑制活性,其 IC50值为 9.5 nM。 | |||
T19913 |
CKI-7
CKI 7 2HCl,CKI-7 dihydrochloride,N-(2-氨基乙基)-5-氯异喹啉-8-磺酰胺二盐酸盐,CKI7 2HCl,CKI 7 dihydrochloride,CKI7 dihydrochloride,CKI-7 2HCl |
ROCK; SGK; Casein Kinase; CDK; S6 Kinase | Cell Cycle/Checkpoint; Cytoskeletal Signaling; MAPK; Metabolism; PI3K/Akt/mTOR signaling; Stem Cells |
CKI-7 是一种有效且 ATP 竞争性的酪蛋白激酶 1 抑制剂,IC50为 6 μM,Ki 为 8.5 μM。它选择性抑制 Cdc7激酶,还抑制 SGK,S6K1以及 MSK1。 | |||
T36720 |
Deacetylforskolin
|
||
Deacetylforskolin is a diterpene and a derivative of forskolin that has been found inC. forskohliiand has diverse biological activities.1,2,3,4It activates rat adipocyte adenylyl cyclase (IC50= 20 μM) and inhibits glucose transport in rat adipocyte plasma membranes.2Deactylforskolin (30-1,000 μg/kg) reduces blood pressure in spontaneously hypertensive rats.3It also attenuates hypercapnia-induced impairments in the passive avoidance response in mice.4 1.Gabetta, B., Zini, G., and Danieli, B.Minor... | |||
T22467 |
1,9-Dideoxyforskolin
|
Others | Others |
The compound is an inactive analog of forskolin(an adenylyl cyclase activator). | |||
T4327 |
Prexasertib dihydrochloride
LY2606368 (dihydrochloride),Prexasertib HCl,LY2606368 |
Apoptosis; Chk; S6 Kinase | Apoptosis; Cell Cycle/Checkpoint; MAPK; PI3K/Akt/mTOR signaling |
Prexasertib dihydrochloride (LY2606368) 是一种选择性的,ATP 竞争性的细胞周期检测点激酶 1 抑制剂,Ki 为 0.9 nM,IC50为 <1 nM。它抑制 CHK2(IC50=8 nM) 和 RSK1 (IC50=9 nM)。它引起双链 DNA 断裂和复制突变,导致细胞凋亡,有抗肿瘤活性。 | |||
TQ0310 |
FMK
|
S6 Kinase | MAPK; PI3K/Akt/mTOR signaling |
FMK 是一种不可逆的 RSK2 抑制剂,能够共价修饰 RSK 的 C 末端区域。 | |||
T7005 |
Ulixertinib
BVD-523,VRT752271,优立替尼 |
ERK | MAPK |
Ulixertinib (VRT752271) 是一种有效且可逆的 ERK1/ERK2 抑制剂,可抑制 ERK2 和下游蛋白 RSK 的磷酸化,对 ERK2 的IC50值小于 0.3 nM。 | |||
T68781 |
3Ac-SL0101
|
||
3Ac-SL0101 is a potent RSK-specific inhibitor. It facilitates the development of RSK inhibitors as anti-cancer chemotherapeutic agents. | |||
T26103 |
RMM-46
|
||
RMM-46 is a reversible and selective covalent inhibitor for MSK/RSK-family kinases. | |||
T11310 |
FMK-MEA
|
Others | Others |
FMK-MEA is a potent and selective p90 Ribosomal S6 Kinase (RSK) inhibitor. | |||
T81041 |
TAS0612
|
Akt | Cytoskeletal Signaling; PI3K/Akt/mTOR signaling |
TAS0612为口服新型抑制剂,具针对性地抑制RSK、AKT和S6K。此化合物展示了通过阻断细胞生长的机制,在多种肿瘤模型中表现出广泛的活性。 | |||
T28695 |
SB-747651A
SB 747651A |
||
SB-747651A is a potent, ATP-competitive inhibitor of mitogen- and stress-activated kinase 1 (MSK1, IC50 = 11 nM). It targets the N-terminal kinase domain. SB-747651A inhibits MSK1, MSK2, PKA, PKB, RSK and p70S6K activity in cells. | |||
T15377 |
Ravoxertinib hydrochloride
GDC-0994 (hydrochloride) |
ERK | MAPK |
Ravoxertinib hydrochloride is an orally bioavailable and selective inhibitor for ERK kinase activity (IC50: 6.1 nM and 3.1 nM for ERK1 and ERK2, respectively). |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T3836 |
Eudesmin
|
MAPK; S6 Kinase | MAPK; PI3K/Akt/mTOR signaling |
Eudesmin 通过抑制S6K1信号通路来干扰成脂分化,具有抗肿瘤、抗炎和抗菌活性。 | |||
T6S1302 |
Carnosol
|
Nrf2; Endogenous Metabolite; S6 Kinase | Immunology/Inflammation; MAPK; Metabolism; PI3K/Akt/mTOR signaling |
Carnosol 是 Nrf2激活剂,增加 Nrf2 的水平以及能促进血红素氧合酶 1(HMOX1) 表达。它是核糖体 S6激酶(RSK2)抑制剂,可用于胃癌相关研究,IC50值约为 5.5 μM。 | |||
T2871 |
Quercitrin
Sophoretin,3-rhamnosyl quercetin,Quercetin 3-rhamnoside,Xanthaurine,槲皮苷,Meletin |
Reactive Oxygen Species; S6 Kinase; Autophagy | Autophagy; Immunology/Inflammation; MAPK; Metabolism; NF-κB; PI3K/Akt/mTOR signaling |
Quercitrin (3-rhamnosyl quercetin) 是苦荞麦中的一种天然产物,具有抗炎作用,有用于心血管疾病的研究潜力。 | |||
T0335 |
Sodium salicylate
水杨酸钠,Salicylic acid sodium salt,2-Hydroxybenzoic acid sodium salt |
Apoptosis; NF-κB; COX; S6 Kinase; Autophagy | Apoptosis; Autophagy; Immunology/Inflammation; MAPK; Neuroscience; NF-κB; PI3K/Akt/mTOR signaling |
Sodium salicylate (2-Hydroxybenzoic acid sodium salt) 是一种S6K 的抑制剂,可抑制COX-2活性。它还是一种NF-κB 抑制剂,可降低炎症基因的表达,促进老化肌肉的修复。 | |||
TN1520 |
Isoforskolin
Coleonol B |
IL Receptor; TNF | Apoptosis; Immunology/Inflammation |
Isoforskolin 源自毛喉鞘蕊花,可减少人单核白细胞中 TNF-α、IL-1β、IL-6 和 IL-8 的分泌。Isoforskolin 可用于治疗莱姆关节炎的研究。 | |||
T2939 |
Forskolin
毛喉素,Coleonol,Colforsin |
FXR; Adenylyl cyclase; AChR; Autophagy | Autophagy; Metabolism; Neuroscience |
Forskolin (Coleonol) 属于天然产物,是一种腺苷酸环化酶激活剂 (EC50=0.5 μM)。Forskolin 可以增加 cAMP 水平,可以激活 PXR 和 FXR,也可以诱导细胞自噬。Forskolin 对心脏产生正性肌力作用,具有血小板抗凝集和降压作用。 | |||
TN4074 |
Forskolin J
|
Others | Others |
Forskolin J 是一种天然产物,可用于生命科学领域的相关研究。其产品编号为 TN4074,CAS号为 81873-08-7。 | |||
TN4073 |
Forskolin G
|
Others | Others |
Forskolin is known to elevate intracellular cAMP levels. | |||
T16896 |
SL 0101-1
SL0101 |
S6 Kinase | MAPK; PI3K/Akt/mTOR signaling |
SL 0101-1 (SL0101) 是一种可透过细胞膜且具有选择性、高效性、可逆性、ATP竞争性的 p90核糖体S6激酶(RSK) 的抑制剂,对 RSK 的 IC50 值为 89 nM。SL 0101-1 (SL0101) 也是一种有效的 RSK1/2 抑制剂,其 Ki 值为 1 μM。 |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPY-04392 |
RSK3 Protein, Human, Recombinant (GST)
HU-2,ribosomal protein S6 kinase, 90kDa, polypeptide 2,S6K-α... |
Human | Baculovirus Insect Cells |
Ribosomal protein S6 kinase alpha-2, also known as 9 kDa ribosomal protein S6 kinase 2, MAP kinase-activated protein kinase 1c, MAPK-activated protein kinase 1c, Ribosomal S6 kinase 3, RSK-3, RPS6KA2 and MAPKAPK1C, is a nucleus protein that belongs to the protein kinase superfamily, AGC Ser/Thr protein kinase family and S6 kinase subfamily. RPS6KA2 / RSK-3 is expressed in many tissues. Highest expression is in lung and skeletal muscle. The expression of RPS6KA2 reduced proliferation, caused G1 a... | |||
TMPY-04357 |
RSK4 Protein, Human, Recombinant (GST)
RSK4,ribosomal protein S6 kinase, 90kDa, polypeptid... |
Human | Baculovirus Insect Cells |
Ribosomal protein S6 kinase alpha-6, also known as Ribosomal S6 kinase 4, 9 kDa ribosomal protein S6 kinase 6,RSK-4, RSK4 and RPS6KA6, is a protein that belongs to the protein kinase superfamily, AGC Ser/Thr protein kinase family and S6 kinase subfamily. RPS6KA6 contains one AGC-kinase C-terminal domain and two protein kinase domains. RPS6KA6 forms a complex with either ERK1 or ERK2 in quiescent cells. RPS6KA6 shows a high level of homology to three isolated members of the human RSK family. RSK2... | |||
TMPY-04540 |
S6K1/RPS6KB1 Protein, Human, Recombinant (GST)
p70(S6K)-alpha,PS6K,p70-alpha,p70(S6K)-α,p70-α,p70 S6KA,S6K-... |
Human | Baculovirus Insect Cells |
PS6K, also known as RPS6KB1, is a serine/threonine-protein kinase. It belongs to the RSK (ribosomal s6 kinase) family. Members of this family function in signal transduction. PS6K is an isoform of p70 ribosomal S6 kinase (S6K). S6K can be activated by mitogenic stimuli such as growth factors, insulin and cytokines. It phosphorylates the ribosomal protein S6. PS6K also phosphorylates other proteins such as elF4B, eEF2K and SKAR. It is a crucial effector of mTOR(rapamycin) signaling. PS6K is disso... |